Association of Patient Comorbidities With Treatment Regret Among Patients With Localized Prostate Cancer – Results From a Population-Based Cohort
Among men with localized prostate cancer, baseline comorbidity burden was associated with increased decision regret. These results illustrate the importance of assessing baseline comorbidities and incorporating their consideration into the treatment decision-making process, ensuring that patients have realistic expectations and make informed decisions.
Authors
- Xinglei Shen (ORCID: https://orcid.org/0000-0003-0337-860X)
- K F Kane (ORCID: https://orcid.org/0009-0003-5548-7880)
- Ying Cao (ORCID: https://orcid.org/0000-0002-4289-452X)
- Aaron J. Katz (ORCID: https://orcid.org/0000-0002-8581-0728)
- Rahul D. Mali (ORCID: https://orcid.org/0000-0002-2259-305X)
- Ronald C. Chen (ORCID: https://orcid.org/0000-0002-4590-8640)
- Deborah Usinger (ORCID: https://orcid.org/0000-0001-6509-7884)
- Yahui Xie
Institutions
- University of North Carolina at Chapel Hill (US)
- University of Kansas Medical Center (US)
Publication Details
- Journal
- Practical Radiation Oncology
- Published
- 2025-08-31
- DOI
- https://doi.org/10.1016/j.prro.2025.07.007
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Health and Human Services
- National Institutes of Health
- Agency for Healthcare Research and Quality
- National Cancer Institute
- National Center for Advancing Translational Sciences